Mitochondrial DNA Polymorphism A4917G Is Independently Associated with Age-Related Macular Degeneration

Male 0301 basic medicine Aging genotype mitochondrial DNA Macular Degeneration single nucleotide polymorphism Reference Values middle aged guanine genetics retina macula age related degeneration primer DNA Fluorescein Angiography apolipoprotein E Genome adult pathogenesis Q complement factor H article R risk assessment Single Nucleotide Middle Aged Mitochondrial aged female Medicine Female Research Article Guanine phenotype Science European Continental Ancestry Group 610 DNA determination Caucasian DNA, Mitochondrial Polymorphism, Single Nucleotide White People 03 medical and health sciences Apolipoproteins E male 616 Humans controlled study human Polymorphism adenine genome Aged DNA Primers Adenine aging reference value retina macula degeneration clinical assessment fluorescence angiography DNA major clinical study age DNA polymorphism population research
DOI: 10.1371/journal.pone.0002091 Publication Date: 2008-05-06T22:28:19Z
ABSTRACT
The objective of this study was to determine if MTND2*LHON4917G (4917G), a specific non-synonymous polymorphism in the mitochondrial genome previously associated with neurodegenerative phenotypes, is increased risk for age-related macular degeneration (AMD). A preliminary 393 individuals (293 cases and 100 controls) ascertained at Vanderbilt revealed an occurrence 4917G compared controls (15.4% vs.9.0%, p = 0.11). Since there significant age difference between initial analysis, we extended by selecting Caucasian pairs matched exact examination. From 1547 Vanderbilt/Duke AMD population association (including 157 study), were able match 560 (280 280 unaffected) on This genotyped plus AMD-associated nuclear polymorphisms CFH, LOC387715 ApoE. Following adjustment listed polymorphisms, independently predicts presence (OR 2.16, 95%CI 1.20–3.91, 0.01). In conclusion, implicated other phenotypes (4917G) appears convey independent recently discovered DNA polymorphisms.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (22)
CITATIONS (89)